Evaluation of the therapeutic efficacy of the developed chitosan enterosorbent in the treatment of acute pancreatitis

The aim of the study is to use chitosan enterosorbent in the treatment of acute pancreatitis in dogs. Methodology: the study was conducted on the basis of the Department of Therapy and Pharmacology of Stavropol State Agrarian University. The objects of the study were dogs of different breeds, which were orally administered this drug. In the course of scientific work, this drug has shown effectiveness in the treatment of acute pancreatitis in dogs of various etiologies, and it was also found that the optimal dose was 1.5 ml / kg of animal weight with an interval of 13 hours. It is worth noting that this drug turned out to be easy to use and had good tolerability.